Focus shifts to maintenance
After PS matching, the difference in treatment effects between patients who received semaglutide and those who received dulaglutide on all-cause death in each subgroup was analyzed, and the crude HR was calculated with the corresponding 95% CIs
Mechanism: GLP-1 Pill vs Dual GIP/GLP-1 Injection Rybelsus (Oral Semaglutide) Rybelsus contains the active ingredient semaglutide formulated with SNAC (salcaprozate sodium), an absorption enhancer that enables oral delivery
In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect
Once-daily oral administration of ID110521156 in diabetic monkeys resulted in reduced plasma glucose levels, increased insulin secretion, decreased food intake, and weight loss
patterns often appear in the timing, not the technique